378 related articles for article (PubMed ID: 30389755)
1. How do type 2 diabetes mellitus (T2DM)-related complications and socioeconomic factors impact direct medical costs? A cross-sectional study in rural Southeast China.
Wu H; Eggleston KN; Zhong J; Hu R; Wang C; Xie K; Chen Y; Chen X; Yu M
BMJ Open; 2018 Nov; 8(11):e020647. PubMed ID: 30389755
[TBL] [Abstract][Full Text] [Related]
2. Direct medical cost of diabetes in rural China using electronic insurance claims data and diabetes management data.
Wu H; Eggleston KN; Zhong J; Hu R; Wang C; Xie K; Chen Y; Chen X; Yu M
J Diabetes Investig; 2019 Mar; 10(2):531-538. PubMed ID: 29993198
[TBL] [Abstract][Full Text] [Related]
3. Assessment of hospital length of stay and direct costs of type 2 diabetes in Hubei Province, China.
Chen D; Liu S; Tan X; Zhao Q
BMC Health Serv Res; 2017 Mar; 17(1):199. PubMed ID: 28288623
[TBL] [Abstract][Full Text] [Related]
4. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
[TBL] [Abstract][Full Text] [Related]
5. Socioeconomic correlates of inpatient spending for patients with type 2 diabetes mellitus in China: evidence from Hangzhou.
Li H; Chen BK; Shah N; Wang Z; Eggleston KN
Exp Clin Endocrinol Diabetes; 2012 Jan; 120(1):35-44. PubMed ID: 22237582
[TBL] [Abstract][Full Text] [Related]
6. Cost-of-illness analysis of type 2 diabetes mellitus in Iran.
Javanbakht M; Baradaran HR; Mashayekhi A; Haghdoost AA; Khamseh ME; Kharazmi E; Sadeghi A
PLoS One; 2011; 6(10):e26864. PubMed ID: 22066013
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing the hospitalization costs of patients with type 2 diabetes.
Cao P; Wang K; Zhang H; Zhao R; Li C
Asia Pac J Public Health; 2015 Mar; 27(2 Suppl):55S-60S. PubMed ID: 25834270
[TBL] [Abstract][Full Text] [Related]
8. Direct non-medical and indirect costs of diabetes and its associated complications in Vietnam: an estimation using national health insurance claims from a cross-sectional survey.
Kieu TTM; Trinh HN; Pham HTK; Nguyen TB; Ng JYS
BMJ Open; 2020 Mar; 10(3):e032303. PubMed ID: 32132135
[TBL] [Abstract][Full Text] [Related]
9. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
Bahia LR; Araujo DV; Schaan BD; Dib SA; Negrato CA; Leão MP; Ramos AJ; Forti AC; Gomes MB; Foss MC; Monteiro RA; Sartorelli D; Franco LJ
Value Health; 2011; 14(5 Suppl 1):S137-40. PubMed ID: 21839888
[TBL] [Abstract][Full Text] [Related]
10. An update on the economic burden of type 2 diabetes mellitus in China.
Ding C; Bao Y; Bai B; Liu X; Shi B; Tian L
Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):617-625. PubMed ID: 34937503
[TBL] [Abstract][Full Text] [Related]
11. Drug usage patterns and treatment costs in newly-diagnosed type 2 diabetes mellitus cases, 2007 vs 2012: findings from a large US healthcare claims database analysis.
Weng W; Liang Y; Kimball ES; Hobbs T; Kong S; Sakurada B; Bouchard J
J Med Econ; 2016 Jul; 19(7):655-62. PubMed ID: 26855139
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Changes in Medical Services and Related Costs in a Single Cohort of Patients Newly Diagnosed With Type 2 Diabetes, 2006 to 2012.
Weng W; Liang Y; Kimball ES; Hobbs T; Kong S; Sakurada B; Bouchard J
Clin Ther; 2016 Jun; 38(6):1314-1326. PubMed ID: 27129399
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the burden of diabetes in Poland].
Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
[TBL] [Abstract][Full Text] [Related]
14. The direct medical cost of type 2 diabetes mellitus in South Africa: a cost of illness study.
Erzse A; Stacey N; Chola L; Tugendhaft A; Freeman M; Hofman K
Glob Health Action; 2019; 12(1):1636611. PubMed ID: 31282315
[No Abstract] [Full Text] [Related]
15. Short-Term Trends in Economic Burden and Catastrophic Costs of Type 2 Diabetes Mellitus in Rural Southwest China.
Li HF; Cai L; Golden AR
J Diabetes Res; 2019; 2019():9626413. PubMed ID: 31467930
[TBL] [Abstract][Full Text] [Related]
16. Ethnic Disparity in Annual Healthcare Expenditures for Type 2 Diabetes Mellitus in Ningxia, China.
Sun X; Liabsuetrakul T; Xie X; Liu P; Zhang Y; Wang Z
J Racial Ethn Health Disparities; 2018 Dec; 5(6):1381-1388. PubMed ID: 29600352
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal study of healthcare utilisation and expenditure in people with type 2 diabetes mellitus with and without major depressive disorder.
Huang CJ; Lin CH; Hsieh HM; Chang CC; Chu CC; Sun DP; Weng SF
Gen Hosp Psychiatry; 2019; 57():50-58. PubMed ID: 30908962
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of direct medical costs of type 2 diabetes in Mali].
Alouki K; Delisle H; Besançon S
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):41-51. PubMed ID: 27889395
[TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes mellitus in China: a preventable economic burden.
Wang W; McGreevey WP; Fu C; Zhan S; Luan R; Chen W; Xu B
Am J Manag Care; 2009 Sep; 15(9):593-601. PubMed ID: 19747024
[TBL] [Abstract][Full Text] [Related]
20. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
